Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice

OBJECTIVE: We aimed to investigate the safety of drug-coated balloon (DCB)-only angioplasty compared to drug-eluting stent (DES), as part of routine clinical practice. BACKGROUND: The recent BASKETSMALL2 trial demonstrated the safety and efficacy of DCB angioplasty for de novo small vessel disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Merinopoulos, Ioannis, Gunawardena, Tharusha, Corballis, Natasha, Bhalraam, U, Gilbert, Tim, Maart, Clint, Richardson, Paul, Ryding, Alisdair, Sarev, Toomas, Sawh, Chris, Sulfi, Sreekumar, Wickramarachchi, Upul, Wistow, Trevor, Mohamed, Mohamed O., Mamas, Mamas A., Vassiliou, Vassilios S., Eccleshall, Simon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449668/
https://www.ncbi.nlm.nih.gov/pubmed/36104455
http://dx.doi.org/10.1007/s00392-022-02106-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449668/
https://www.ncbi.nlm.nih.gov/pubmed/36104455
http://dx.doi.org/10.1007/s00392-022-02106-y

Ejemplares similares